Pfenex gets FDA nod for potential Forteo genericForteo had a global market value of $1.6 billion in 2018. Fresenius Kabi introduces generic FaslodexFresenius Kabi developed its fulvestrant injection prefilled syringe to be stable at room temperature, so that it doesn't require refrigeration. Alembic launches generic Optivar Alembic's azelastine ophthalmic solution 0.05% is provided as 6mL in a sterile dispensing bottle. MedicaSafe partners with Amneal on generic Suboxone monitoring MedicaSafe will combine Amneal's generic of Suboxone (buprenorphine and naloxone) with its smart medication systems to treat opioid dependence. Perrigo relaunches generic Transderm Scop Transderm Scop and generics had a market value of roughly $147 million for the 12 months ending August 2019. Lannett enters into distribution agreement for generic Advair Diskus Under the agreement, Lanett will begin U.S. distribution of Respirent’s generic once the product receives the Food and Drug Administration’s approval. Pfizer reportedly to launch Avastin biosimilar in December Pfizer is planning to launch its Avastin biosimilar, Zirabev, on Dec. 31, according to a Camber intros generic Xyzal Camber’s generic is indicated to relieve allergy symptoms. Teva launches generic Remodulin injection Teva’s generic Remodulin is available in multi-dose 20 ml vials in dosage strengths of 1 mg/ml, 2.5 mg/ml, 5 mg/ml and 10 mg/ml. FDA approves Zydus’ generic Clobex lotion Clobetasol propionate lotion is indicated to treat such skin conditions as eczema, psoriasis, dermatitis, allergies and rash. First Previous 175 176 177 178 179 Next Last
